Theravance Biopharma, Inc. - COM (TBPH)

Historical Portfolio Holders from Q2 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
46.3 M
Holdings value Q1 2024
$415 M
Value change Q1 2024
-$11.5 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
114
Number of buys Q1 2024
48
Number of sells Q1 2024
-61
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
G8807B106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 46.3 M $415 M -$11.5 M $8.97 114
2023 Q4 48.5 M $545 M -$40.4 M $11.24 115
2023 Q3 50.8 M $438 M -$16.2 M $8.63 112
2023 Q2 52.3 M $541 M -$81.3 M $10.35 115
2023 Q1 60.1 M $652 M -$19.3 M $10.85 112
2022 Q4 61.9 M $694 M -$39.7 M $11.22 117
2022 Q3 57.8 M $586 M -$970 K $10.14 108
2022 Q2 58.9 M $533 M +$8.9 M $9.06 102
2022 Q1 57.8 M $553 M +$32.3 M $9.56 111
2021 Q4 52.7 M $582 M -$17.1 M $11.05 103
2021 Q3 60.1 M $445 M -$37.8 M $7.40 111
2021 Q2 60.7 M $882 M +$106 M $14.52 102
2021 Q1 53.5 M $1.09 B +$7.58 M $20.41 108
2020 Q4 53.2 M $945 M +$17.4 M $17.77 99
2020 Q3 52.2 M $771 M -$4.43 M $14.78 110
2020 Q2 52.2 M $1.1 B +$23.3 M $20.99 115
2020 Q1 55 M $1.27 B +$249 M $23.11 97
2019 Q4 44.8 M $1.16 B +$118 M $25.89 101
2019 Q3 46.2 M $900 M -$26.3 M $19.48 85
2019 Q2 36.3 M $592 M +$40 M $16.33 89
2019 Q1 48.4 M $1.1 B +$14.6 M $22.67 96
2018 Q4 47.7 M $1.22 B -$166 K $25.59 91
2018 Q3 47.4 M $1.55 B +$9.88 M $32.67 90
2018 Q2 47.8 M $1.08 B +$18.5 M $22.68 81
2018 Q1 47.7 M $1.16 B +$19.3 M $24.25 87
2017 Q4 46.9 M $1.31 B -$13.5 M $27.89 79
2017 Q3 47.3 M $1.62 B +$33.5 M $34.24 83
2017 Q2 46.2 M $1.84 B +$26.5 M $39.84 90
2017 Q1 45.1 M $1.66 B +$168 M $36.82 93
2016 Q4 43.8 M $1.4 B +$264 M $31.88 96
2016 Q3 35.3 M $1.28 B +$76.6 M $36.24 99
2016 Q2 33.9 M $770 M +$132 M $22.69 94
2016 Q1 28 M $526 M +$42.7 M $18.80 75
2015 Q4 25.9 M $425 M +$86.2 M $16.39 77
2015 Q3 20.5 M $226 M -$24.5 M $10.99 77
2015 Q2 22.2 M $288 M +$16.3 M $13.02 83
2015 Q1 20.9 M $362 M +$7.47 M $17.35 82
2014 Q4 20.3 M $303 M -$33.6 M $14.92 85
2014 Q3 21.1 M $486 M +$14.3 M $23.05 83
2014 Q2 20.2 M $644 M +$644 M $31.88 87